This website uses cookies to improve your experience. Learn more about cookies and how to manage them.



New advisory group to provide interim support on use of medicines for COVID-19

17 Jun 2020

The COVID-19 Therapeutics Advice & Support Group (CTAG), aiming to support the evidence-based use of medicines in relation to COVID-19, has been endorsed by the Society and the British Infection Association.

Announcing our award winners

12 Jun 2020

The Society is celebrating the achievements of our members by announcing the recipients of our prizes and awards.

International societies call on researchers to apply clinical pharmacology principles in search for safe and effective treatments for COVID-19

09 Jun 2020

Today, the British Pharmacological Society and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists publish a joint international statement calling on researchers to apply clinical pharmacology principles in search for safe and effective treatments for COVID-19. The statement was published in the British Journal of Clinical Pharmacology and endorsed by organisations* across the world.  

Society comment on #BlackLivesMatter

02 Jun 2020

The Society includes a diversity of people from all backgrounds for whom we will provide an environment that supports their endeavours, celebrates their achievements, and removes any systemic barriers to their participation. This is embedded in our strategy, which has set the stage for the work we have started and are committed to. However, we must acknowledge that racism is structurally embedded into systems and processes across our society, including within science and health. This has a...

Society publishes position on animal models and COVID-19

29 May 2020

Animal models used in the global effort to find a treatment for COVID-19 must be valid – and they must be used and reported consistently.

New joint FORUM report highlights importance of investing in the clinical research workforce

28 May 2020

The ambitions to conduct more clinical research in the UK could be achieved by strategic investment in the clinical research workforce, according to new joint FORUM report, Shaping the future training and employment environment for clinical research.  

Society supports call that visas for international scientists must be competitively costed

26 May 2020

The Society has joined partner organisations in the UK research and innovation sector in calling for competitively costed visas for international scientists.

Society responds to government's COVID-19 recovery strategy

12 May 2020

The government has published its COVID-19 recovery strategy, ‘Our plan to rebuild’, setting out a series of phases as part of this plan. Phase three recognises the critical importance of accelerating the development of an effective vaccine or treatments.

Society responds to new roadmap for identifying COVID-19 treatments

07 May 2020

A new review, publishing in the British Journal of Pharmacology, from a team of researchers representing the International Union of Basic and Clinical Pharmacology (IUPHAR), identifies opportunities for drug discovery in the treatment of COVID-19.

Society publishes positions on medicines use and development relating to COVID-19

23 Apr 2020

The Society has formulated positions on key issues relating to the COVID-19 pandemic that impact upon pharmacology and clinical pharmacology. ‚Äč